Purchase Order 75N92020P00287

<p>The National Heart Lung and Blood Institute awarded a purchase order to Keyence Corporation Of America on September 6, 2019, for an all-in-one fluorescence microscope, with a ceiling value of $99,261.18. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of October 6, 2019. The solicitation was posted August 27, 2019, with a due date of September 3, 2019.</p>

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $301,248.16 purchase order contract to Life Technologies Corporation for the purchase of a high content confocal microscope and fluorescent microscope. The prime contractor, Life Technologies Corporation, will provide the microscopes from its location in Carlsbad, California. Performance is scheduled to be completed by August 23, 2023 under a firm fixed price contract type....

<p>The National Heart Lung and Blood Institute awarded a purchase order to Formulatrix, LLC for a microscope system valued at $52,357.00 on September 6, 2018, under a total small business set-aside. Work is performed in Bedford, Massachusetts. The order is firm fixed price and carries an ultimate completion date of October 6, 2018. The requirement originated from a solicitation posted August 29, 2018, with a due date of September 5, 2018.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to FEI Company for a cryo-electron microscope system valued at $2,769,275 on September 26, 2018. Performance occurs in Hillsboro, Oregon. The order is firm fixed price with no set-aside. Ultimate completion is scheduled for September 30, 2020. The solicitation posted September 13, 2018 with a due date of September 20, 2018.</p>

<p>The National Heart Lung and Blood Institute issued a $39,486.45 delivery order to Government Scientific Source Inc. on May 8, 2019, under the GSA Multiple Award Schedule (FSS-66) for an EVOS M5000 integrated microscopy system to visualize and analyze cells under metabolic stress at the Laboratory Biochemical Genetics.</p> <p>Place of performance is Reston, VA. The order has a firm fixed price structure with an ultimate completion date of May 17, 2019.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Leica Microsystems Inc. for a microscope valued at $12,895.68 on September 10, 2020, with completion by October 10, 2020. Performance occurs in Buffalo Grove, Illinois. No set-aside was used; the award was made on an unrestricted, open basis.</p>

The Food and Drug Administration awarded a purchase order to Life Technologies Corporation for $119,438.59 on September 20, 2022, for five EVOS XL CORE inverted light microscope imaging systems and two EVOS M5000 inverted fluorescence imaging systems, including shipping, inside delivery, installation, training, and a one-year manufacturer's warranty of parts. No set-aside was used. Work is performed at Laurel, Maryland. The order is firm fixed price with an ultimate completion date of...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Life Technologies Corporation for an iBright CL1500 imaging system valued at $24,501.00 on August 20, 2021. Place of performance is Frederick, Maryland. The order carries a firm fixed price and an ultimate completion date of November 19, 2021.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Leica Microsystems Inc. for a Leica M80 surgical dissecting stereomicroscope on September 7, 2021, with a ceiling value of $16,006.06 and a completion date of November 30, 2021. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Life Technologies Corporation for an iBright imaging system on April 20, 2018, with a ceiling value of $32,201.00 and an ultimate completion date of May 20, 2018. Place of performance is Bethesda, Maryland. The order carries firm fixed price and no set-aside designation.</p>